STOCK TITAN

Arrowhead officer amends notice for $750K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144/A

Rhea-AI Filing Summary

Arrowhead Pharmaceuticals, Inc. (ARWR) officer James Hamilton amended a Form 144 notice covering the proposed sale of 10,000 common shares, with an aggregate market value of $749,997.60 and an approximate sale date of April 23, 2026. The notice identifies December 2, 2025, as the date the Rule 10b5-1 plan was adopted. It also reports that Hamilton sold 10,000 common shares on March 5, 2026, for gross proceeds of $641,870.05 during the preceding three months.

Proposed shares to be sold 10,000 shares Common shares; approximate sale date April 23, 2026
Aggregate market value $749,997.60 Proposed sale of common shares
Shares outstanding 140,032,190 shares Number of common shares outstanding stated in the notice
Shares sold 10,000 shares Sale reported for March 5, 2026
Gross proceeds $641,870.05 Sale reported for March 5, 2026
Rule 10b5-1 plan adoption date December 2, 2025 Date identified in the amended notice
Rule 10b5-1 regulatory
"Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Aggregate Market Value financial
"Number of Shares or Other Units To Be Sold | Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Gross Proceeds financial
"Amount of Securities Sold | Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ARWR shares does James Hamilton plan to sell?

The notice covers a proposed sale of 10,000 common shares, with an aggregate market value of $749,997.60 and an approximate sale date of April 23, 2026.

When was James Hamilton's Rule 10b5-1 plan adopted?

The plan adoption date listed in the amended notice is December 2, 2025.

What prior ARWR share sale does the notice report for James Hamilton?

The notice reports that Hamilton sold 10,000 common shares on March 5, 2026, for gross proceeds of $641,870.05.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144/A: Filer Information

144/A: Issuer Information

144/A: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

144/A: Remarks and Signature

Keep reading